Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.08
Bid: 0.065
Ask: 0.08
Change: 0.00 (0.00%)
Spread: 0.015 (23.077%)
Open: 0.08
High: 0.08
Low: 0.08
Prev. Close: 0.0725
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£1.93m strategic investment by Graphene Lab

9 Apr 2021 07:00

RNS Number : 9534U
Versarien PLC
09 April 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

9 April 2021

Versarien plc

("Versarien" or the "Company")

£1.93 million strategic investment in Versarien by Graphene Lab

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has entered into a wide-ranging series of agreements (together the "Agreement") with Graphene Lab Co Ltd ("Graphene Lab"), a South Korean based company specialising in chemical vapor deposition ("CVD") graphene, including sensors, OLEDs, and flexible transparent touch panels, with the intention of advancing both Versarien's and Graphene Lab's proposed activities in South Korea. This follows the Company's acquisition of certain graphene production related assets and intellectual property from South Korea based Hanwha Aerospace Co. Ltd (the "Acquisition"), as announced on 22 December 2020.

 

In addition, Graphene Lab has made a strategic investment of £1.93 million in the Company through a subscription for 4,280,000 new Ordinary Shares (the "Subscription Shares") at an issue of price of 45 pence per Ordinary Share (the "Issue Price"). The Subscription Shares, which represent 2.2% of the enlarged share capital of the Company, will be subject to a 12-month lock-in.

 

Further information on the Agreement

 

Graphene Lab has entered into the Agreement with the Company's wholly owned subsidiary in South Korea, Versarien Korea Ltd ("Versarien Korea"). The Agreement covers a number of matters pertaining to Versarien and Graphene Lab's proposed activities in South Korea. The main elements of the Agreement are summarised below:

 

· The Agreement provides a licence to Graphene Lab to utilise, exclusively in South Korea, 14 of the patents acquired through the Acquisition for a 5% royalty on sales payable to Versarien;

· Under the Agreement, Graphene Lab has the right to use certain Versarien trademarks on payment of a 2% royalty on sales to Versarien;

· Graphene Lab will acquire 15% of the shares in Versarien Korea at their nominal value and the board of Versarien Korea will, in due course, comprise five directors, of which four will be nominated by Versarien and one by Graphene Lab;

· Graphene Lab has leased new premises in South Korea and Versarien Korea is taking a sub-lease over part of that facility, to locate the equipment acquired as part of the Acquisition. Additionally, Versarien Korea and Graphene Lab have agreed to share equipment at an agreed daily rate; and

· Graphene Lab will provide certain operator and maintenance support to Versarien Korea at an agreed cost.

 

Admission and Total Voting Rights

 

The Subscription Shares will rank pari passu with the existing Ordinary Shares and application has been made for their admission to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 13 April 2021.

 

Following the issue of the Subscription Shares, the Company will have 194,149,790, ordinary shares of 1 pence each in issue. The figure of 194,149,790 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Neill Ricketts, CEO of Versarien, commented: "We are delighted to have secured this agreement with Graphene Lab, which will enable us to advance our plans in South Korea, following the Acquisition in December. I am also pleased that our partnership with Graphene Lab has been further reinforced by the stake they have taken in Versarien. We are excited by the opportunities for Versarien in South Korea, including for new product developments, and we look forward to providing updates in due course."

 

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1242 269 122

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Henry Wilkinson

Versarien@yellowjerseypr.com

+44 (0)774 778 8221

Notes to Editors:

 

Versarien Plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

 

For further information please see: http://www.versarien.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGXGDSIXGDGBC
Date   Source Headline
6th Jun 20247:00 amRNSInterim Results for six months ended 31 March 2024
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.